We have recently shown a correlation between the level of ligand independence, signalling activation, and phenotypic consequences of different FGFR3 mutations expressed in normal urothelial cells and their frequency in UC, suggesting that the spectrum of FGFR3 mutations in bladder tumours may relate to selection for their potency [49]. Here, FGFR3 is linked to urinary bladder neoplasm.